EGFR and non-small cell lung carcinoma: The successful application of DST to a treatment‐naive EGFR‐mutant NSCLC patient emphasizes the potential of utilizing DST combined with advanced cell isolation techniques in guiding personalized treatment strategies for NSCLC patients.